If you have been NEWLY DIAGNOSED START HERE
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
For our Mandarin-speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
For our Mandarin-speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our...
GRACE brings you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving with cancer. Our...
History- Diagnosis in February, metastasis to thyroid, lymph nodes, chest wall. Malignant pleural effusion-had pleurex cathether which was recently removed due to little fluid. Pdl1 40%, KRAS mutation
The Global Resource for Advancing Cancer Education (GRACE), in partnership with Georgetown University Hospital is pleased to present the videos from the panel discussion "2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know".
Dr. Vamsidhar Velcheti with the Cleveland Clinic joined GRACE to discuss updates to our Lung Cancer Video Library. In this video, Dr. Velcheti discusses MET as a target in advanced non-small cell lung cancer.
Dr. Alice Shaw joined GRACE to discuss patterns of resistance in ALK positive non small cell lung cancer.
March 26, 2018 at 10:40 pm #1294138
March 26, 2018 at 8:36 pm #1294136
onthemark
I’ve got two stable ground glass small lesions (one 5 mm and another faint one 5x9mm) in my right lung and have been reading about other people’s experiences with them on the web.
On a different forum it is often stated that these lesions rarely grow large, but I thought it was the case that they can grow large but are not called AIS when they grow to larger than 3 cm so it is only a question of definition rather than related to the natural life history of these lesions.
March 20, 2018 at 2:04 pm #1294118
JimC Forum Moderator
JimC Forum Moderator
If you’d like to stay informed about the latest GRACE developments, you can subscribe to our free GRACE Notes newsletter. Just fill in the form here and never miss another update!
March 17, 2018 at 8:12 am #1294101
masalovai
I have stage 4 NSCLC adenocarcinoma with bone metastasis. I started carboplatin Alimta Avastin chemo treatment and wondering if this triplet is effectively treating bone metastasis as well….. I am also receiving zoledronic acid every three weeks , but it does treat bone mets.
There are very limited publications related to effectiveness of standard chemo on bone metastasis. I’ve found that targeted drugs such Erlotinib and gifatinib are very effective in treating bone metastasis.
March 22, 2018 at 11:53 pm #1294125
March 18, 2018 at 1:24 am #1294108
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock